499 related articles for article (PubMed ID: 8548765)
1. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.
Lin KY; Guarnieri FG; Staveley-O'Carroll KF; Levitsky HI; August JT; Pardoll DM; Wu TC
Cancer Res; 1996 Jan; 56(1):21-6. PubMed ID: 8548765
[TBL] [Abstract][Full Text] [Related]
2. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.
Ji H; Wang TL; Chen CH; Pai SI; Hung CF; Lin KY; Kurman RJ; Pardoll DM; Wu TC
Hum Gene Ther; 1999 Nov; 10(17):2727-40. PubMed ID: 10584920
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
Kang TH; Lee JH; Bae HC; Noh KH; Kim JH; Song CK; Shin BC; Hung CF; Wu TC; Park JS; Kim TW
Immunol Lett; 2006 Aug; 106(2):126-34. PubMed ID: 16844231
[TBL] [Abstract][Full Text] [Related]
4. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
[TBL] [Abstract][Full Text] [Related]
5. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.
Wu TC; Guarnieri FG; Staveley-O'Carroll KF; Viscidi RP; Levitsky HI; Hedrick L; Cho KR; August JT; Pardoll DM
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11671-5. PubMed ID: 8524826
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin.
Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC
Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
Cheng WF; Hung CF; Hsu KF; Chai CY; He L; Ling M; Slater LA; Roden RB; Wu TC
Hum Gene Ther; 2001 Feb; 12(3):235-52. PubMed ID: 11177561
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver.
Chen CH; Suh KW; Ji H; Choti MA; Pardoll DM; Wu TC
J Hepatol; 2000 Jul; 33(1):91-8. PubMed ID: 10905591
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimen.
Kim TW; Lee JH; He L; Boyd DA; Hung CF; Wu TC
Hum Gene Ther; 2005 Jan; 16(1):26-34. PubMed ID: 15703486
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein.
Ji H; Chang EY; Lin KY; Kurman RJ; Pardoll DM; Wu TC
Int J Cancer; 1998 Sep; 78(1):41-5. PubMed ID: 9724092
[TBL] [Abstract][Full Text] [Related]
11. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
[TBL] [Abstract][Full Text] [Related]
12. Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines.
Chen CH; Wang TL; Hung CF; Pardoll DM; Wu TC
Vaccine; 2000 Apr; 18(19):2015-22. PubMed ID: 10706963
[TBL] [Abstract][Full Text] [Related]
13. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC
Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccines against HPV-16 E7-expressing tumour cells.
De Marco F; Hallez S; Brulet JM; Gesché F; Marzano P; Flamini S; Marcante ML; Venuti A
Anticancer Res; 2003; 23(2B):1449-54. PubMed ID: 12820408
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
[TBL] [Abstract][Full Text] [Related]
16. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes.
Hung CF; Cheng WF; He L; Ling M; Juang J; Lin CT; Wu TC
Cancer Res; 2003 May; 63(10):2393-8. PubMed ID: 12750257
[TBL] [Abstract][Full Text] [Related]
17. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells.
Rowell JF; Ruff AL; Guarnieri FG; Staveley-O'Carroll K; Lin X; Tang J; August JT; Siliciano RF
J Immunol; 1995 Aug; 155(4):1818-28. PubMed ID: 7636236
[TBL] [Abstract][Full Text] [Related]
18. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.
Smahel M; Síma P; Ludvíková V; Marinov I; Pokorná D; Vonka V
Vaccine; 2003 Mar; 21(11-12):1125-36. PubMed ID: 12559790
[TBL] [Abstract][Full Text] [Related]
19. Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.
Kang TH; Lee JH; Noh KH; Han HD; Shin BC; Choi EY; Peng S; Hung CF; Wu TC; Kim TW
Int J Cancer; 2007 Apr; 120(8):1696-703. PubMed ID: 17230516
[TBL] [Abstract][Full Text] [Related]
20. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
